XENEXENON PHARMACEUTICALS INC
CUSIP 98420N105 · common stock
2 tracked investors held XENON PHARMACEUTICALS INC (XENE) at the end of Q3 2026, worth $57M in total. The largest holder was Adar1 Capital Management, with 1.8% of its portfolio. 3 investors sold out this quarter, including Stanley Druckenmiller.
Holders · Q3 2026
2
New holders
0
Value held
$57M
Quarter-end price (est.)
$37.19
Investors holding XENE · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Adar1 Capital Management ADAR1 Capital Management, LLC | 1.84% | 1,162,029 | $43.2M | ADD+597.7% |
| Julian Baker Baker Bros. Advisors LP | 0.07% | 370,208 | $13.8M | HOLD |
Sold out this quarter
| Investor | Prior weight | Prior shares | Prior value | Change |
|---|---|---|---|---|
| Stanley Druckenmiller | 0.28% | 238,600 | $14.4M | EXIT |
| Chuck Royce | 0.03% | 65,032 | $3.9M | EXIT |
| Ron Baron | 0.00% | 25,000 | $1.5M | EXIT |